Biliary Disease

Sobia Siddiqui


Pearls

  • ERCP is not available at VA: requires transfer to VUMC, contact GI to arrange HEMATOLOGY-ONCOLOGY 120.
  • Prior cholecystectomy -> CBD normally dilates to 8-10 mm, not necessarily pathological (consider further workup if >10 mm with elevated bilirubin).
  • Pneumobilia generally indicates prior biliary sphincterotomy and/or biliary stent.
  • CBD dilation classically >6mm, but CBD dilates with age: 70 yo -> 7mm, 80 yo -> 8mm; opiates can also cause biliary dilatation.

Acute Calculous Cholecystitis

  • Inflammation of the GB from an obstructing stone in the GB neck or cystic duct.
  • Ddx: PUD, pancreatitis, choledocholithiasis, ascending cholangitis, IBD, Fitz-Hugh Curtis.
  • Presentation: Severe constant RUQ pain, fever/chills, N/V, + Murphy sign.
  • Evaluation: CBC (leukocytosis), CMP (mild AST/ALT ↑), Lipase, Lactate, BCx x2. Tokyo Criteria (2018): need 1x each of local inflammation (pain, Murphy’s sign), systemic inflammation (leukocytosis, fever), imaging (CT or U/S).
  • Imaging: RUQ U/S: gallstones + GB wall thickening (>3 mm) or pericholecystic edema.
  • If U/S non-diagnostic (no stones or GB inflammation)à HIDA Scan (lack of GB filling).

Management: NPO, IVF, IV Abx until resolved or surgical removal

  • Urgent Cholecystectomy (<72H) with EGS.
  • If poor surgical candidate: Cholecystostomy with IR; endoscopic drainage options for select patients (i.e. poor surgical candidates also with ascites).
    • Complications: gangrenous cholecystitis, perforation, emphysematous cholecystitis, cholecysto- enteric fistula, gallstone ileus.

Acute Acalculous Cholecystitis

Inflammation of the GB without obstructing stone (due to stasis and ischemia)

  • Presentation: Seen in critically ill/ICU pts; similar history as above; may present as unexplained fever or RUQ mass (rarely jaundice).
  • Ddx: calculous cholecystitis, pancreatitis, hepatic abscess.
  • Evaluation: Same as acute calculous cholecystitis.
  • Imaging: GB wall thickening, pericholecystic edema, intramural gas, GB distention.

Management: Supportive care, antibiotics, GB drainage

  • IVF, correct electrolyte abnormalities, NPO.
  • Broad spectrum antibiotic coverage.
  • Laparoscopic cholecystectomy is preferred for pts who are not severely ill.
  • For severely ill pts: Place CT-guided procedure consult for cholecystostomy placement vs Endoscopic drainage (transpapillary cystic duct stent via ERCP or cholecystoduodenostomy by EUS).
  • Consult EGS if necrosis, perforation, or emphysematous changes present.

Biliary Colic

  • Transient biliary obstruction typically at the GB neck without GB inflammation (no fever).
  • Presentation: Constant (not colicky), intense, dull RUQ pain and N/V for 30 minutes to 6 hours, then resolves, provoked by fatty foods (CCK), absent Murphy’s sign.
  • Evaluation: Normal (CBC, LFTs, Lipase, Lactate).
  • Imaging: RUQ U/S: cholelithiasis (stones in GB).
  • Management: Elective cholecystectomy as outpatient.

Choledocholithiasis

  • Obstruction of biliary outflow by CBD stone without inflammation (no fever) 
  • Impacted cystic duct stone (cholecystitis) with compression of the CBD (Mirizzi syndrome) 
  • Presentation: RUQ pain (can be painless), N/V and jaundice 
  • Evaluation: CMP and D-bili (Bili/ALP/ GGT ↑↑↑, AST/ALT mild ↑), CBC (leukocytosis suggests cholangitis), Lipase 
  • Imaging: RUQ U/S: dilated CBD (>6 mm with GB, >8 mm without GB) à MRCP/EUS vs ERCP (see below) 
    • MRCP preferred given non-invasive but has lower sensitivity for smaller stones (consider EUS if still have suspicion despite negative MRCP or if patient contraindication to/intolerance of MRI).

Approach to Choledocholithiasis

Choledocholithiasis Chart

ASGE 2019 Risk Stratification for Choledocholithiasis

RiskClinical and Imaging FeaturesManagement
HighCBD stone on imaging OR clinical acute cholangitis
OR Tbili >4 mg/dL AND dilated CBD (>6 mm with GB, >8 mm without GB)
Proceed directly to ERCP
IntermediateAbnormal liver enzymes OR Age >55 OR Dilated CBD on U/SEUS, MRCP, or intraoperative cholangiography (IOC) before ERCP
LowNo predictors presentCholecystectomy without IOC

Management

  • NPO & IVF, pain control PRN.
  • Procedures as per above algorithm.
  • See Acute Cholangitis section If concerned for acute cholangitis.

Acute Cholangitis

  • Bacterial infection of biliary tract 2/2 obstruction (typically stones) or prior instrumentation (ERCP). 
  • Patients with malignant obstruction develop cholangitis less commonly than stone disease, but risk increases significantly after instrumentation (ERCP/stenting).
  • Presentation: Charcot triad (RUQ pain, fever, jaundice); Reynolds’ Pentad (+AMS, hypotension).
  • Evaluation: CBC, CMP (Dbili, ALP ↑↑↑) Blood Cultures, Lipase, Lactate, CRP, AST/ALT can be ↑↑ as well.
  • Imaging: RUQ U/S: dilated CBD (ULN is 6mm), no need for MRCP/EUS prior to ERCP.
    • Consider MRCP overnight if ERCP is not being done emergently.

Management

  • NPO, IVF, broad-spectrum antibiotics.
  • Consult GI for urgent/emergent ERCP (generally within 24-48 hr).
  • If ERCP not feasible or fails to establish biliary drainage, can consider EUS-guided biliary drainage, percutaneous transhepatic cholangiography, or surgical decompression.
  • Duration of antibiotics: 3-5 days after adequate source control; extend to 2 weeks if Enterococcus or Streptococcus bacteremia (risk of endocarditis).
  • Cholecystectomy generally needed within 72 hours of ERCP.

Last updated on